Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
J Clin Invest (2014) 124(6):245663
Another factor to consider is the cost and the commitment
The trial is a 68 week study in adults with obesity and knee osteoarthritis, but without diabetes
Patients on tirzepatide lost an average of 20.2% of their body weight over 72 weeks, compared to 13.7% with semaglutide.[1] That gap is not small, and for patients in Shreveport asking which medication is the better choice, this study provides the clearest evidence yet
Baseline data for the cohort is in Supplementary Table S1, and groups and dosing are listed in Supplementary Table S2
Life Sci 325:121784
US$ 28.52
US$ 27.09
US$ 23.63
US$ 22.12
US$ 20.80
US$ 29.33
US$ 25.79
US$ 27.11
